Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations
Carl E. Orringer, Lale Tokgozoglu, Kevin C. Maki and 3 more
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease · 2020
doi:10.1161/jaha.120.018189 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Despite consensus that excessive circulating concentrations of apoB‐lipoproteins is a key driver for the atherosclerotic process and that treatments that low‐density lipoprotein cholesterol lowering by up‐regulation of low‐density lipoprotein cholesterol receptor expression reduces that risk, divergent viewpoints on interpretation of study data have resulted in substantial differences in European and American lipid guideline recommendations. This article explores those differences and highlights the importance of understanding guideline‐based lipid management to improve patient care and reduce the risk of clinical atherosclerotic cardiovascular disease.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.